Does insulin resistance and hyperglycemia lead to low T3 and high reverse T3 through impaired peripheral conversion?

Metabolic health and thyroid function are intricately linked through shared biochemical pathways. Mounting evidence suggests that insulin resistance and elevated blood glucose levels can fundamentally alter how the body processes thyroid hormones, often leading to a physiological state characterized by low active T3 and elevated inactive reverse T3 (rT3).

Clinical and effectiveness evidence

In clinical settings, markers of insulin resistance, such as HOMA-IR and HbA1c, frequently correlate with lower levels of free T3 (FT3) in both euthyroid individuals and those with type 2 diabetes.

• Studies have shown that as insulin sensitivity decreases, the ratio of active T3 to inactive T4 often declines, suggesting a bottleneck in peripheral conversion.
• In patients with metabolic syndrome or significant hyperglycemia, clinicians frequently observe a "non-thyroidal illness syndrome" (NTIS) pattern, where the body's metabolic rate is downregulated as a response to systemic stress.
• While rT3 is not always measured in routine practice, the biochemical shift toward T4 inactivation (rT3) rather than activation (T3) is a hallmark of this metabolic adaptation.

Mechanistic explanations

The disruption of thyroid conversion is primarily driven by the dysregulation of deiodinase enzymes (D1, D2, and D3) through specific inflammatory and oxidative pathways:

• Enzymatic Shunting: High glucose and insulin resistance trigger the release of pro-inflammatory cytokines like TNF-α, IL-6, and IL-1β. These cytokines downregulate the Type 1 deiodinase (D1), the main enzyme responsible for converting T4 to active T3 in the liver and kidneys.
• Activation of D3: Simultaneously, these inflammatory signals can upregulate Type 3 deiodinase (D3), which actively converts T4 into rT3, essentially "shunting" thyroid hormone into an inactive form.
• Oxidative Stress: Hyperglycemia-induced reactive oxygen species (ROS) deplete glutathione (GSH) and selenium. Since deiodinases are selenium-dependent enzymes, this depletion directly inhibits the body's ability to produce active T3.
• Feedback Loops: This reduced T3 availability may further worsen insulin resistance by impairing GLUT4-mediated glucose uptake, creating a self-reinforcing cycle of metabolic dysfunction.

Bottom line

Insulin resistance and hyperglycemia are strongly associated with impaired thyroid conversion. This occurs because inflammatory and oxidative stress signals inhibit the enzymes that create active T3 while promoting the production of inactive rT3. Managing glucose levels may be a critical factor in optimizing peripheral thyroid hormone metabolism.